Reyataz
Payments companies reported to CMS as associated with Reyataz. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Reyataz, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Reyataz
These are the largest totals companies reported as associated with Reyataz. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ricardo Pollitt | Plymouth, MA | Dermatology | $30.15 |
| Tivon Sidorsky | Plymouth, MA | Dermatology | $30.15 |
| Nicole Giardino | Plymouth, MA | Family | $30.15 |
| Mark Hughes | Norwell, MA | Adult Health (Nurse Practitioner) | $30.15 |
| Ather Mehboob | Loma Linda, CA | Internal Medicine | $24.46 |
| Neeraj Agnihotri | Palmdale, CA | Hematology & Oncology | $24.46 |
| Gurpreet Jawanda | Bakersfield, CA | Nurse Practitioner | $24.46 |
| Vikas Ghai | Bakersfield, CA | Hematology & Oncology | $24.46 |
| Alexis Devens | Yonkers, NY | Family | $22.65 |
| Robert Snyder | Pembroke Pines, FL | Dermatology | $10.74 |
Prescribed Reyataz?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.